JPWO2021065306A1 - - Google Patents

Info

Publication number
JPWO2021065306A1
JPWO2021065306A1 JP2021550469A JP2021550469A JPWO2021065306A1 JP WO2021065306 A1 JPWO2021065306 A1 JP WO2021065306A1 JP 2021550469 A JP2021550469 A JP 2021550469A JP 2021550469 A JP2021550469 A JP 2021550469A JP WO2021065306 A1 JPWO2021065306 A1 JP WO2021065306A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021550469A
Other languages
Japanese (ja)
Other versions
JP7718270B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021065306A1 publication Critical patent/JPWO2021065306A1/ja
Priority to JP2025042343A priority Critical patent/JP2025098086A/ja
Application granted granted Critical
Publication of JP7718270B2 publication Critical patent/JP7718270B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2440/00—Post-translational modifications [PTMs] in chemical analysis of biological material
    • G01N2440/14—Post-translational modifications [PTMs] in chemical analysis of biological material phosphorylation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
JP2021550469A 2019-09-30 2020-09-02 血液試料を検体とするタウタンパク質検出方法 Active JP7718270B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025042343A JP2025098086A (ja) 2019-09-30 2025-03-17 血液試料を検体とするタウタンパク質検出方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019179385 2019-09-30
JP2019179385 2019-09-30
PCT/JP2020/033211 WO2021065306A1 (ja) 2019-09-30 2020-09-02 血液試料を検体とするタウタンパク質検出方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025042343A Division JP2025098086A (ja) 2019-09-30 2025-03-17 血液試料を検体とするタウタンパク質検出方法

Publications (2)

Publication Number Publication Date
JPWO2021065306A1 true JPWO2021065306A1 (cg-RX-API-DMAC7.html) 2021-04-08
JP7718270B2 JP7718270B2 (ja) 2025-08-05

Family

ID=75338154

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021550469A Active JP7718270B2 (ja) 2019-09-30 2020-09-02 血液試料を検体とするタウタンパク質検出方法
JP2025042343A Pending JP2025098086A (ja) 2019-09-30 2025-03-17 血液試料を検体とするタウタンパク質検出方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025042343A Pending JP2025098086A (ja) 2019-09-30 2025-03-17 血液試料を検体とするタウタンパク質検出方法

Country Status (4)

Country Link
US (1) US20220365102A1 (cg-RX-API-DMAC7.html)
EP (1) EP4040153A4 (cg-RX-API-DMAC7.html)
JP (2) JP7718270B2 (cg-RX-API-DMAC7.html)
WO (1) WO2021065306A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7718270B2 (ja) 2019-09-30 2025-08-05 ニプロ株式会社 血液試料を検体とするタウタンパク質検出方法
JP7629468B2 (ja) 2020-10-20 2025-02-13 日鉄マイクロメタル株式会社 半導体装置用Ａｇ合金ボンディングワイヤ
EP4409299A4 (en) * 2021-10-01 2025-08-13 Integrated Neurologics LLC METHODS AND DEVICES FOR DETECTING CEREBROSPINAL FLUID LEAKAGE
WO2024214588A1 (ja) * 2023-04-13 2024-10-17 国立研究開発法人量子科学技術研究開発機構 被験者の脳のタウタンパク質の蓄積量を推定する方法及び装置
JP7450995B1 (ja) 2023-04-13 2024-03-18 国立研究開発法人量子科学技術研究開発機構 被験者の脳のタウタンパク質の蓄積量を推定する方法及び装置

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5492812A (en) * 1991-08-01 1996-02-20 Provost, Fellows And Scholars Of Trinity College Diagnostic method for Alzheimer's disease by screening for tau-peptides in the blood of a patient
JPH08503898A (ja) * 1992-03-05 1996-04-30 ロウバー グループ リミテッド 複式射出成形方法および当該方法で形成される成形体
US20150018223A1 (en) * 2010-01-28 2015-01-15 University Of Massachusetts Lowell Methods of diagnosing tau-associated neurodegenerative diseases
WO2017138497A1 (ja) * 2016-02-08 2017-08-17 シスメックス株式会社 被検物質の検出方法および被検物質の検出用試薬キット
JP2017531796A (ja) * 2014-09-30 2017-10-26 ワシントン・ユニバーシティＷａｓｈｉｎｇｔｏｎ Ｕｎｉｖｅｒｓｉｔｙ タウの動態測定
WO2018106776A2 (en) * 2016-12-07 2018-06-14 Genentech, Inc. Anti-tau antibodies and methods of use
JP2019027952A (ja) * 2017-07-31 2019-02-21 京都府公立大学法人 リン酸化タウタンパク質の測定方法
US20190271710A1 (en) * 2018-03-05 2019-09-05 Janssen Pharmaceutica Nv Assays to detect neurodegeneration
WO2020105700A1 (ja) * 2018-11-22 2020-05-28 富士レビオ株式会社 抗体コンジュゲート

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU690092B2 (en) * 1992-12-14 1998-04-23 N.V. Innogenetics S.A. Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications
JP2002040023A (ja) * 2000-07-28 2002-02-06 Mitsubishi Chemicals Corp アルツハイマー病の検出方法
TWI700296B (zh) 2012-05-31 2020-08-01 公立大學法人大阪市立大學 失智症治療劑或預防劑
JP7718270B2 (ja) 2019-09-30 2025-08-05 ニプロ株式会社 血液試料を検体とするタウタンパク質検出方法

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5492812A (en) * 1991-08-01 1996-02-20 Provost, Fellows And Scholars Of Trinity College Diagnostic method for Alzheimer's disease by screening for tau-peptides in the blood of a patient
JPH08503898A (ja) * 1992-03-05 1996-04-30 ロウバー グループ リミテッド 複式射出成形方法および当該方法で形成される成形体
US20150018223A1 (en) * 2010-01-28 2015-01-15 University Of Massachusetts Lowell Methods of diagnosing tau-associated neurodegenerative diseases
JP2017531796A (ja) * 2014-09-30 2017-10-26 ワシントン・ユニバーシティＷａｓｈｉｎｇｔｏｎ Ｕｎｉｖｅｒｓｉｔｙ タウの動態測定
WO2017138497A1 (ja) * 2016-02-08 2017-08-17 シスメックス株式会社 被検物質の検出方法および被検物質の検出用試薬キット
WO2018106776A2 (en) * 2016-12-07 2018-06-14 Genentech, Inc. Anti-tau antibodies and methods of use
JP2019027952A (ja) * 2017-07-31 2019-02-21 京都府公立大学法人 リン酸化タウタンパク質の測定方法
US20190271710A1 (en) * 2018-03-05 2019-09-05 Janssen Pharmaceutica Nv Assays to detect neurodegeneration
WO2020105700A1 (ja) * 2018-11-22 2020-05-28 富士レビオ株式会社 抗体コンジュゲート

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEN ZHICHENG ET AL.: "Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzh", ALZHEIMER'S & DEMENTIA, vol. 15, no. 3, JPN6020043680, 9 November 2018 (2018-11-09), pages 487 - 496, ISSN: 0005485379 *

Also Published As

Publication number Publication date
EP4040153A4 (en) 2023-07-26
JP7718270B2 (ja) 2025-08-05
WO2021065306A1 (ja) 2021-04-08
JP2025098086A (ja) 2025-07-01
EP4040153A1 (en) 2022-08-10
US20220365102A1 (en) 2022-11-17

Similar Documents

Publication Publication Date Title
BR112019017762A2 (cg-RX-API-DMAC7.html)
BR112019016141A2 (cg-RX-API-DMAC7.html)
AU2020104490A5 (cg-RX-API-DMAC7.html)
BR112019016142A2 (cg-RX-API-DMAC7.html)
BR112019016138A2 (cg-RX-API-DMAC7.html)
BR112021012348A2 (cg-RX-API-DMAC7.html)
BR112021013128A2 (cg-RX-API-DMAC7.html)
BR112019016136A2 (cg-RX-API-DMAC7.html)
BR102019023359A2 (cg-RX-API-DMAC7.html)
BR102020025461B1 (pt) Dispositivo e processo de conversão de compostos aromáticos por alquilação de benzeno por etileno
BR102020020816B1 (pt) Veículo, e, método para controlar o movimento de ar através de um veículo com uma ventoinha do veículo
BR102020017390B1 (pt) Bomba multifásica
BR102020011722B1 (pt) Porta de tela para um pacote de radiadores
BR102020005984B1 (pt) Dispositivo de arranque-gerador combinado, e, conjunto de trem de acionamento
BR102020005860B1 (pt) Controle de obstrução para um implemento agrícola
BR112021012379B1 (pt) Material de aço adequado para uso em ambiente ácido
BR112021012064B1 (pt) Sistema e método de previsão de risco de ataque de insetos
BR112021013352B1 (pt) Processo e dispositivo para endireitar arame ou material de fita
BR112021010564B1 (pt) Sistema de armadilha para animais e método de monitoramento do mesmo
BR112021013954B1 (pt) Sistema de cateter com confirmação da colocação do cateter dentro de uma veia
BR102020000355B1 (pt) Embreagem que tem dois estágios para aplicar torque variado entre um eixo de entrada e um eixo de saída
BR102019027339B1 (pt) Sistema de aspersão de água e difusor de sistema de aspersão de água
BR102019026542B1 (pt) Sistema para detectar e controlar a posição de spoiler de asa de aeronave
BR102019026215B1 (pt) Sinalizador acústico
BR102019026293B1 (pt) Sistema de aeronave, e, método para transmitir energia de um primeiro componente para um segundo componente

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230623

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240730

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240927

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20241217

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250317

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250422

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250526

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250624

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250707

R150 Certificate of patent or registration of utility model

Ref document number: 7718270

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150